Trinity Biotech (TRIB) Non Operating Investment Income (2015 - 2016)

Trinity Biotech's (TRIB) quarterly Non Operating Investment Income came in at -$3.1 million in Q3 2016, down 132.05% year-on-year from $9.6 million in Q4 2015, and down 132.05% quarter-over-quarter from $9.6 million in Q3 2015.

Trinity Biotech (TRIB) Non Operating Investment Income (2015 - 2016) Analysis & Trends

Trinity Biotech has disclosed Non Operating Investment Income across 2 years of filings, most recently posting -$3.1 million for Q3 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Trinity Biotech 23,520.00 -5.11 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2016 -3.09 Mn
Sep 30, 2016 -3.09 Mn
Sep 30, 2015 9.63 Mn
Sep 30, 2015 9.63 Mn